Systemic Inflammation in Severe Infectious Diseases

  • 20k

    Total downloads

  • 60k

    Total views and downloads

About this Research Topic

Submission closed

Background

Hospital-acquired infections are common and often result in life-threatening complications, mostly facing critically ill patients in the intensive care unit. Patients with hospital-acquired infections may die from bacteremia/fungal/viral infection or hyperinflammatory complications because of an uncontrolled over-activation of the innate immune system with pathological levels of circulating proinflammatory cytokines, or from multiorgan failure. In addition to eliciting a robust inflammatory response, it paradoxically renders the host in an immunocompromised state at the late stage of the disease progression. Severe infectious diseases, including sepsis and septic shock are among the most common reasons for death in hospitals. Sepsis is an infection-induced syndrome characterized by a generalized inflammatory state and represents a frequent complication in surgical patients and in immunocompromised patients. Sepsis is a common, expensive, and frequently associated with a fatal outcome. Every 3 to 4 seconds somebody dies with sepsis, and it is one of the leading causes of death worldwide.

Clinical symptoms of patients suffering from infectious diseases are a culmination of complex interactions between the infecting microorganism and host immune responses. This in turns leads to an induction of overwhelming inflammatory reactions, systemic activation of the complement and coagulation systems, and impaired fibrinolysis. Currently, diagnosis relies on non-specific physiological criteria and culture-based pathogen detection. This results in diagnostic uncertainty, therapeutic delays, misuse and/or overuse of antibiotics, as well as the failure to identify patients who might benefit from immunomodulatory therapies. Traditional antibiotic treatments, however, are only able to remove the invading pathogen, but they cannot interfere with complications caused by pathologic host responses. Thus, it is obvious that there is an urgent need for novel therapeutic approaches addressing many invasive infections and sepsis.

Diagnosis- The concept of “personalized medicine” leads on to the idea of personalized or precision medicine, in which treatments are tailored to individuals. An immune biomarker is defined as any characteristic that can be objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacological responses to a therapeutic intervention. Recent progress in genomics, molecular immunology and proteomics, coupled with an increasing focus on translational research, has given rise to a real expectation that we are entering an era of personalized medicine, in which non-invasive technologies are used to predict, diagnose, prevent and treat a diverse range of diseases. Nonetheless, the ability of a biomarker to distinguish between groups is measured by sensitivity, specificity and stability or similar variance estimates.

Treatment- Infections often lead to poor healing, there a risk of an unnecessary use of antibiotics that may contribute to the development of resistances and an increase in health care costs. Therefore, new knowledge on pathogenesis of infections and novel concepts dealing with innovative preventive measures are urgently needed. Moreover, there is clearly a demand for novel therapeutic strategies for sepsis, and correspondingly, also a need for increased knowledge on host defense molecules and their actions, like endogenously produced/generated proteins or peptide are interesting novel natural drug candidates against infectious diseases.

In this Research Topic, we welcome submissions in the form of Original Research articles, Reviews, Mini-Reviews, Clinical trials, and Perspectives that summarize and explore new insights focusing particularly on systemic inflammation observed in infectious diseases. We welcome manuscripts focusing on, but not limited to, the following sub-topics:

• Dysregulation of hemostatic functions in sepsis.
• Systemic modulation of inflammatory host reactions.
• Pathologic activation of complement.
• Biomarker as target for precision medicine approaches.
• Target identification for clinical therapy development.
• Dysfunctional innate immune reactions in severe infectious diseases.

Topic Editor Mukesh Pasupuleti is employed by Council of Scientific & Industrial Research, New Delhi, India. Topic Editor Julien Pottecher reports grants from LFB Biomedicaments Research grant, educational grant, advisory board (2019) during the conduct of the study; grants from Masimo Educational grant, grants from Edwards Lifesciences Educational grant, grants from AOP Orphan Educational grant, and grants from RDS Advisory board outside the scope of the Research Topic. The other Topic Editors in this editorial team declare no conflict of interest.

Keywords: Inflammation, Immunity, Biomarkers, Sepsis, Bacteria, Host Defense, Peptides, Proteins

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Frequently asked questions

  • Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

    Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

  • The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

    Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

  • As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

    A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

  • Each Research Topic must be approved by the specialty chief editor, and it falls under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

    In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

  • Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

    As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

    Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

  • Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

    Check available article types here 

  • Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

    Suggest your topic here 

  • A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

    The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

  • As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

    You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

  • As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

  • If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

  • Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

  • Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

  • As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

    Find out more about our Research Topics

  • Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

    Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

  • In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.

Impact

  • 60kTopic views
  • 38kArticle views
  • 20kArticle downloads
View impact